NCT01140789
GWA Study in Patients With Inflammatory Bowel Disease
Recruiting · Not specified · Chinese University of Hong Kong · registry updated 2023-02-08
Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.
The aim of this study is to identify new genes in Chinese patients that help investigators to understand the biological pathway and functions in a population in whom the incidence of Inflammatory Bowel Disease (IBD) is increasing. And to explore the genetic variations in Chinese patients with IBD.
Inclusion
- Age 18 or above
- Informed consent given by patient or family
- Case group (IBD patients) Diagnosis of Crohn's disease or ulcerative colitis defined by endoscopy, radiology and histology
- Control group (non-IBD cases) Ethically, sex and aged-matched controls attending clinics or endoscopy for functional upper gastrointestinal diseases or screening colonoscopy.
Exclusion
- Controls will be excluded if they have previously been diagnosed with IBD or if they have a first or second degree relative with IBD.